Browse by:
Research & Development

Alexion reports flat 1Q profits

Keith Griffin |

New Haven biopharma Alexion said Thursday its first-quarter profits were largely flat from a year earlier, despite 17 percent revenue growth.

Breaking silos: the big 'C' in CT's bioscience ambitions is collaboration

Gregory Seay |

Connecticut has taken steps to pull its largest research universities — UConn and Yale — out of their “silos'' and promote collaboration between them and the broader marketplace for...

Alexion to celebrate New Haven move

On Monday, Feb. 29, Alexion Pharmaceuticals will celebrate its official return to New Haven and the opening of its new global headquarters with a building dedication and ribbon-cutting ceremony.

Copyright 2016 New England Business Media